TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
TELA Bio (NASDAQ: TELA) will present at the Piper Sandler 37th Annual Healthcare Conference. Management is scheduled to present on December 3, 2025 at 2:30 pm ET. Interested parties can access a live and archived webcast at the company's investor site: ir.telabio.com.
The presentation highlights the company’s participation at a major healthcare investor conference and provides a webcast option for remote access.
TELA Bio (NASDAQ: TELA) parteciperà alla Piper Sandler 37th Annual Healthcare Conference. La dirigenza è prevista presentare il 3 dicembre 2025 alle 14:30 ET. Gli interessati possono accedere a una diretta e webcast archiviata sul sito investitore dell'azienda: ir.telabio.com.
La presentazione evidenzia la partecipazione dell'azienda a una importante conferenza di investitori nel settore sanitario e fornisce un'opzione di webcast per l'accesso a distanza.
TELA Bio (NASDAQ: TELA) participará en la Piper Sandler 37th Annual Healthcare Conference. Se espera que la dirección presente el 3 de diciembre de 2025 a las 2:30 p.m. ET. Las partes interesadas pueden acceder a un webcast en vivo y archivado en el sitio de inversionistas de la empresa: ir.telabio.com.
La presentación destaca la participación de la empresa en una importante conferencia de inversionistas del sector salud y ofrece una opción de webcast para acceso remoto.
TELA Bio (NASDAQ: TELA)는 Piper Sandler 37th Annual Healthcare Conference에서 발표할 예정입니다. 경영진은 2025년 12월 3일 동부표준시 14:30에 발표하도록 예정되어 있습니다. 이해관계자는 회사의 투자자 사이트에서 생방송 및 보관된 웹캐스트에 접속할 수 있습니다: ir.telabio.com.
발표는 회사의 주요 의료 분야 투자자 회의 참여를 강조하고 원격 접속을 위한 웹캐스트 옵션을 제공합니다.
TELA Bio (NASDAQ: TELA) participera à la Piper Sandler 37th Annual Healthcare Conference. La direction est prévue pour présenter le 3 décembre 2025 à 14h30 ET. Les parties intéressées peuvent accéder à un webcast en direct et archivé sur le site des investisseurs de l'entreprise : ir.telabio.com.
La présentation met en évidence la participation de l'entreprise à une importante conférence d'investisseurs du secteur de la santé et propose une option de webcast pour un accès à distance.
TELA Bio (NASDAQ: TELA) wird auf der Piper Sandler 37th Annual Healthcare Conference auftreten. Die Geschäftsführung wird voraussichtlich am 3. Dezember 2025 um 14:30 Uhr MEZ präsentieren. Interessierte können über die Website des Unternehmens für Investoren auf einen Live- und Archiv-Webcast zugreifen: ir.telabio.com.
Die Präsentation hebt die Teilnahme des Unternehmens an einer bedeutenden Gesundheits-Investorenkonferenz hervor und bietet eine Webcast-Option für den Remote-Zugang.
TELA Bio (NASDAQ: TELA) ستقدم في Piper Sandler 37th Annual Healthcare Conference. من المتوقع أن يعقد الإدارة عرضاً في 3 ديسمبر 2025 الساعة 2:30 مساءً بتوقيت شرق الولايات المتحدة. يمكن لأطراف المهتمين الوصول إلى البث المباشر والمسجّل في موقع المستثمرين للشركة: ir.telabio.com.
تسلط الإحاطة الضوء على مشاركة الشركة في مؤتمر مستثمرين رفيع المستوى في الرعاية الصحية وتوفر خيار البث للوصول عن بُعد.
- None.
- None.
MALVERN, Pa., Nov. 19, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in Piper Sandler’s 37th Annual Healthcare Conference.
TELA’s management is scheduled to present at Piper Sandler’s 37th Annual Healthcare Conference at 2:30 pm ET on December 3rd, 2025. Interested parties can access the live and archived webcast at ir.telabio.com.
About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.
Investor Contact
Louisa Smith
ir@telabio.com